Arvinas (ARVN) EBT (2017 - 2026)
Arvinas (ARVN) posted quarterly EBT of -$57.5 million for Q1 2026, down 169.19% year-over-year from $83.1 million in Q1 2025, and up 14.43% quarter-over-quarter from -$67.2 million in Q4 2025.
Arvinas (ARVN) EBT (2017 - 2026) Analysis & Trends
Arvinas' EBT history runs 10 years deep, the most recent figure standing at -$57.5 million for Q1 2026.
- In Q1 2026, EBT fell 169.19% year-over-year to -$57.5 million; the TTM figure through Mar 2026 stood at -$221.0 million (down 380.43% YoY), while the FY2025 annual figure was -$80.5 million, up 59.4% from the prior year.
- EBT for Q1 2026 stood at -$57.5 million, up from -$67.2 million in the prior quarter.
- The five-year high for EBT was $83.1 million in Q1 2025, with the low at -$153.2 million in Q4 2023.
- The 5-year median for EBT is -$61.5 million (2025), against an average of -$56.0 million.
- The sharpest annual moves came in 2025 and 2026: EBT jumped 219.91% in 2025, then tumbled 169.19% in 2026.
- Arvinas' EBT stood at -$69.3 million in 2022, then tumbled by 121.07% to -$153.2 million in 2023, then surged by 70.3% to -$45.5 million in 2024, then slumped by 47.69% to -$67.2 million in 2025, then climbed by 14.43% to -$57.5 million in 2026.
- Business Quant data shows ARVN's EBT at -$57.5 million in Q1 2026, -$67.2 million in Q4 2025, and -$34.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Arvinas | 585.74 Mn | 17.84 Mn | - | 169.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 169.60 Mn |
| Mar 31, 2026 | -57.50 Mn |
| Dec 31, 2025 | -67.20 Mn |
| Sep 30, 2025 | -34.80 Mn |
| Jun 30, 2025 | -61.50 Mn |
| Mar 31, 2025 | 83.10 Mn |
| Dec 31, 2024 | -45.50 Mn |
| Sep 30, 2024 | -48.60 Mn |
| Jun 30, 2024 | -35.00 Mn |
| Mar 31, 2024 | -69.30 Mn |
| Dec 31, 2023 | -153.20 Mn |
| Sep 30, 2023 | -63.90 Mn |
| Jun 30, 2023 | -65.60 Mn |
| Mar 31, 2023 | -81.20 Mn |
| Dec 31, 2022 | -69.30 Mn |
| Sep 30, 2022 | -61.10 Mn |
| Jun 30, 2022 | -64.10 Mn |
| Mar 31, 2022 | -56.60 Mn |
| Dec 31, 2021 | -46.10 Mn |
| Sep 30, 2021 | -46.80 Mn |